𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Potential of Proprotein Convertase Subtilisin/Kexin Type 9 Based Therapeutics

✍ Scribed by Stein, Evan A.; Swergold, Gary D.

Book ID
120648353
Publisher
Current Science Inc.
Year
2013
Tongue
English
Weight
381 KB
Volume
15
Category
Article
ISSN
1523-3804

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Proprotein convertase subtilisin/kexin t
Proprotein convertase subtilisin/kexin type 9: A new target molecule for gene therapy
✍ Anna Banaszewska; Michal Piechota; Robert Plewa πŸ“‚ Article πŸ“… 2012 πŸ› SP Versita 🌐 English βš– 341 KB

## Abstract Proprotein convertase subtilisin/kexin type 9 (PCSK9) has emerged as a novel target for controlling plasma levels of low-density lipoprotein cholesterol (LDL-C) and decreasing the risk of cardiovascular diseases. At present it is clear that the major classes of commonly prescribed lipid